September 29th is World Heart Day. Created by the World Heart Federation, it’s a day that aims to raise global awareness around Cardiovascular disease (CVD), which includes heart disease and strokes. Cardiovascular disease is responsible for nearly half of all noncommunicable diseases deaths making it the world’s number one killer. Therefore, World Heart Day is an opportunity for us to consider not just our current heart health but what role genetics may play in predicting if we have any propensity for heart disease or stroke in the future.Read More
The PhosphorusONE test looks at the most exhaustive list of genes known to cause inherited cancer syndromes. Understanding whether or not you or a loved one carries a mutation in these genes can help catch cancer before it’s too late.Read More
The PhosphorusONE test is the first genetic test that examines genes responsible for various forms of infertility and can help guide decisions on everything from egg freezing to fertility treatments.
The most recent research shows that genetic causes underpin at least 10 – 15% of the causes of infertility. Understanding earlier in life whether or not you have a genetic risk factor can help you make a more informed decision as to how, and even when you approach having a child.Read More
Hygea Precision Medicine, Inc. (Hygea), a company focused on developing a precision medicine software system for healthcare providers and patients to effectively manage genomic testing, and Phosphorus, a leader in diagnostic and bioinformatic solutions for clinical next generation sequencing (NGS), are pleased to announce a formal, agreed partnership. In addition, technical integration between the two platforms has been successfully completed.Read More